Definitive Healthcare's (DH) Hold Rating Reiterated at Needham & Company LLC

Definitive Healthcare (NASDAQ:DH - Get Free Report)'s stock had its "hold" rating reissued by research analysts at Needham & Company LLC in a research note issued on Thursday,Benzinga reports.

Other equities research analysts have also issued reports about the stock. Stephens started coverage on shares of Definitive Healthcare in a research note on Friday, December 20th. They set an "equal weight" rating and a $5.00 price target on the stock. Barclays reaffirmed an "underweight" rating and set a $4.00 price target on shares of Definitive Healthcare in a research report on Monday. Two analysts have rated the stock with a sell rating, six have assigned a hold rating and three have issued a buy rating to the company. According to data from MarketBeat.com, Definitive Healthcare currently has a consensus rating of "Hold" and an average target price of $5.72.

Definitive Healthcare Stock Up 0.1 %

DH stock traded up $0.01 during trading on Thursday, hitting $3.99. 170,842 shares of the company's stock were exchanged, compared to its average volume of 248,523. The stock has a market capitalization of $460.35 million, a price-to-earnings ratio of -1.29, a PEG ratio of 3.26 and a beta of 1.41. The company has a current ratio of 2.49, a quick ratio of 2.49 and a debt-to-equity ratio of 0.33. Definitive Healthcare has a 52-week low of $3.19 and a 52-week high of $10.62. The business has a 50-day moving average price of $4.36 and a two-hundred day moving average price of $4.51.

Insider Activity at Definitive Healthcare

In other news, insider William Moschella sold 45,000 shares of the stock in a transaction that occurred on Tuesday, December 3rd. The stock was sold at an average price of $4.70, for a total transaction of $211,500.00. Following the completion of the transaction, the insider now directly owns 433,830 shares of the company's stock, valued at approximately $2,039,001. This represents a 9.40 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. 14.84% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of DH. Point72 DIFC Ltd grew its holdings in shares of Definitive Healthcare by 759.9% in the 3rd quarter. Point72 DIFC Ltd now owns 9,296 shares of the company's stock worth $42,000 after acquiring an additional 8,215 shares during the period. Intech Investment Management LLC purchased a new position in shares of Definitive Healthcare in the third quarter valued at $55,000. Bleakley Financial Group LLC purchased a new stake in shares of Definitive Healthcare in the 3rd quarter worth about $74,000. Glenmede Trust Co. NA grew its stake in Definitive Healthcare by 41.1% in the 3rd quarter. Glenmede Trust Co. NA now owns 18,423 shares of the company's stock valued at $82,000 after acquiring an additional 5,362 shares during the last quarter. Finally, SG Americas Securities LLC purchased a new position in Definitive Healthcare during the 3rd quarter valued at about $84,000. Hedge funds and other institutional investors own 98.67% of the company's stock.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.